FDA Approves First-in-Class Therapy for Hereditary Angioedema
Dawnera (donidalorsen) is now approved by the U.S. Food and Drug Administration (FDA) as the first-ever and only therapy targeting ...
We’re Heading to ESMO Congress 2025 in Berlin
We’re pleased to confirm our participation at the ESMO Congress 2025 in Berlin, Germany, one of the most important oncology ...
Takeda’s Qdenga Vaccine: A Breakthrough in Dengue Prevention Coming to India
What is Qdenga, and how does it work? Takeda developed Qdenga as a tetravalent dengue vaccine. It protects against all ...
Indian Company Can Manufacture Risdiplam for Spinal Muscular Atrophy (SMA)
In a major development, a leading Indian pharmaceutical company, Natco Pharma, has been given approval to produce Risdiplam. This is ...
FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors
Introduction: The Promise of Qfitlia for Hemophilia Treatment The FDA has authorized Qfitlia (Fitusiran), a new treatment for both Hemophilia ...
FDA Approves First Treatment for a Rare Lipid Storage Disease
On February 21, 2025, the Food and Drug Administration of the United States (FDA) approved Ctexli (chenodiol) for CTX therapy ...
FDA Approves Tenecteplase for Acute Ischemic Stroke (AIS)
Recently, the U.S. Food and Drug Administration (FDA) approved TNKase (tenecteplase) for the use of treating adults with acute ischemic ...
First Generic GLP-1 Injection to Treat Type 2 Diabetes is Approved by FDA
On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) ...
WHO Approves World’s First Diagnostic Test for MPox
The World Health Organization (WHO) has taken a critical step in improving global access to MPox testing by listing the ...